Vantive ApS: Financial statements 2025
CVR: 44201666
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Vantive ApS (CVR 44201666) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 87,089,842 and a net result of DKK 3,905,382 compared with DKK 4,825,752 the year before. That is an increase of 3.2% compared with the year before. The profit margin was 4.5%. Equity in the 2025 report amounted to DKK 20,572,247. The solvency ratio was 35.7%. The company had 19 employees in the financial year.
- Revenue
- DKK 87,089,842
- Gross Profit
- DKK 18,225,621
- Profit/Loss
- DKK 3,905,382
- Equity
- DKK 20,572,247
- Total Assets
- DKK 57,693,536
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 87.1 mio. | 18.2 mio. | 3.9 mio. | 20.6 mio. | 19 |
| 2024 | 84.4 mio. | 23.4 mio. | 4.8 mio. | 16.7 mio. | 15 |
How creditworthy is Vantive ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Vantive ApS has published its annual report for 2024. Revenue came to DKK 84,356,926, and the net result was DKK 4,825,752.
About Vantive ApS
Vantive ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2023. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BXT Renal ApS. The management consists of Marianne Schjelderup Brodersen. The company is owned by Vantive Holding B.V.. In 2025, the company reported revenue of DKK 87,089,842 and a net result of DKK 3,905,382 compared with DKK 4,825,752 the year before. Equity in the 2025 report amounted to DKK 20,572,247.